RA0017

antibody from Oursmab

Targeting: AOC3 HPAO, VAP-1, VAP1

Western blot (Supportive data in Antibodypedia)

ELISA (Recommended by provider)

Immunocytochemistry (Recommended by provider)

Flow cytometry (Recommended by provider)

Functional assay (Recommended by provider)

Antibody Data

Product number

RA0017

Provider

Oursmab

Product name

Timolumab (Biosimilar Reference Antibody) (AOC3)

Antibody type

Monoclonal

Description

Timolumab is a recombinant fully human IgG4 kappa monoclonal antibody targeting vascular adhesion protein-1 (VAP-1), a cell surface enzyme (amine oxidase) expressed on endothelial cells and involved in leukocyte trafficking and inflammation. It binds to VAP-1 to inhibit its enzymatic activity and adhesion function, thereby reducing immune cell infiltration into tissues. It is being developed for the treatment of inflammatory and fibrotic diseases, such as nonalcoholic steatohepatitis (NASH) and diabetic kidney disease.

Reactivity

Human

Isotype

IgG

Vial size

100 ¦Ìg,1 mg,5 mg,10 mg,25 mg,50 mg,100 mg

Concentration

Bottled at the concentration indicated on the vial.

Storage

Store at -20¡ãC or -80¡ãC. Avoid repeated freeze.

Western blot

Supportive validation

Submitted by

Oursmab (provider)

Main image

Experimental details

Timolumab (Biosimilar Reference Antibody) (AOC3)-RA0017-Oursmab determined by SDS-PAGE. The purity of the protein is greater than 98%.